Daniel M. Weibel

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience.

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience.

Journal: Clinical epidemiology
Published: August 08, 2025

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources.

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources.

Journal: Vaccines
Published: May 30, 2025

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.

Journal: Vaccine
Published: May 30, 2025

Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases.

Comparison of Adverse Events in Pregnant Persons Receiving COVID-19 and Influenza Vaccines: A Disproportionality Analysis Using Combined Data from US VAERS and EudraVigilance Spontaneous Report Databases.

Journal: Drug safety
Published: May 08, 2025

COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials.

COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials.

Journal: Vaccine
Published: January 10, 2025

Real-World Evidence BRIDGE: A Tool to Connect Protocol With Code Programming.

Real-World Evidence BRIDGE: A Tool to Connect Protocol With Code Programming.

Journal: Pharmacoepidemiology and drug safety
Published: July 30, 2024

Experiences and perceptions about vaccines and reporting of adverse events following immunisation: a qualitative study among mothers in Northern Ghana.

Experiences and perceptions about vaccines and reporting of adverse events following immunisation: a qualitative study among mothers in Northern Ghana.

Journal: BMJ public health
Published: July 17, 2024

Barriers and strategies to improve vaccine adverse events reporting: views from health workers and managers in Northern Ghana.

Barriers and strategies to improve vaccine adverse events reporting: views from health workers and managers in Northern Ghana.

Journal: BMJ public health
Published: May 15, 2024

Authors' Reply to Juergen O Kirchner's Comment on "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project".

Authors' Reply to Juergen O Kirchner's Comment on "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project".

Journal: Drug safety
Published: April 17, 2023

COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)-A Systematic Review of Study Designs and Methods.

COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)-A Systematic Review of Study Designs and Methods.

Journal: Vaccines
Published: April 03, 2023

Documenting capacity and existing gaps in reporting adverse events following immunisation in Northern Ghana: a quantitative cross-sectional survey of healthcare workers.

Documenting capacity and existing gaps in reporting adverse events following immunisation in Northern Ghana: a quantitative cross-sectional survey of healthcare workers.

Journal: BMJ public health
Published: March 27, 2023

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study.

Journal: Vaccine
Published: February 23, 2022
Showing 1-12 of 52

Last Updated: 09/26/2026